NCT04068896 2025-05-29Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNGM Biopharmaceuticals, IncPhase 1/2 Completed89 enrolled 21 charts
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT01962103 2019-12-27Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCelgenePhase 1/2 Completed107 enrolled 42 charts
NCT00864253 2019-10-30A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant MelanomaCelgenePhase 3 Completed529 enrolled 22 charts
NCT00093119 2017-04-26Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCelgenePhase 2 Completed75 enrolled
NCT01933061 2014-02-04Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic MelanomaCelgenePhase 2 Withdrawn
NCT00409383 2011-11-07Abraxane and Temodar Plus Genasense in Advanced MelanomaGenta IncorporatedPhase 1 Unknown28 enrolled